← Back to all trials
Active Not Recruiting
NCT07064486
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Conditions: Type 2 Diabetes (T2DM)
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 152
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Location: RS Universitas Indonesia Depok West Java
Summary
This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes
Eligibility Criteria
Inclusion Criteria:
* ○ Have been diagnosed with type 2 diabetes mellitus (T2DM);
* Be on stable treatment with unchanged dose of metformin ≥1500 mg/day or \
Source: ClinicalTrials.gov (NCT07064486). StuddyBuddy aggregates publicly available trial information.
